Annual Retained Earnings
-$140.75 M
-$26.24 M-22.91%
December 31, 2022
Summary
- As of February 10, 2025, ACER annual retained earnings is -$140.75 million, with the most recent change of -$26.24 million (-22.91%) on December 31, 2022.
- During the last 3 years, ACER annual retained earnings has fallen by -$64.50 million (-84.59%).
Performance
ACER Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Retained Earnings
-$165.12 M
-$8.09 M-5.15%
June 30, 2023
Summary
- As of February 10, 2025, ACER quarterly retained earnings is -$165.12 million, with the most recent change of -$8.09 million (-5.15%) on June 30, 2023.
- Over the past year, ACER quarterly retained earnings has dropped by -$38.76 million (-30.68%).
Performance
ACER Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ACER Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -22.9% | -30.7% |
| 3 y3 years | -84.6% | -89.9% |
| 5 y5 years | -450.8% | -380.4% |
ACER Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | +22.9% | at low | +44.2% | at low |
| 5 y | 5-year | +84.6% | at low | +116.5% | at low |
| alltime | all time | >+9999.0% | +14.6% | >+9999.0% | at low |
Acer Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | -$165.12 M(+5.2%) |
| Mar 2023 | - | -$157.03 M(+11.6%) |
| Dec 2022 | -$140.75 M(+22.9%) | -$140.75 M(+7.1%) |
| Sep 2022 | - | -$131.36 M(+4.0%) |
| Jun 2022 | - | -$126.36 M(+2.2%) |
| Mar 2022 | - | -$123.69 M(+8.0%) |
| Dec 2021 | -$114.51 M(+15.5%) | -$114.51 M(+4.0%) |
| Sep 2021 | - | -$110.09 M(+6.0%) |
| Jun 2021 | - | -$103.88 M(+3.2%) |
| Mar 2021 | - | -$100.65 M(+1.5%) |
| Dec 2020 | -$99.14 M(+30.0%) | -$99.14 M(+6.7%) |
| Sep 2020 | - | -$92.90 M(+6.8%) |
| Jun 2020 | - | -$86.97 M(+7.1%) |
| Mar 2020 | - | -$81.20 M(+6.5%) |
| Dec 2019 | -$76.25 M(+62.8%) | -$76.25 M(+7.3%) |
| Sep 2019 | - | -$71.09 M(+8.0%) |
| Jun 2019 | - | -$65.84 M(+20.1%) |
| Mar 2019 | - | -$54.80 M(+17.0%) |
| Dec 2018 | -$46.83 M(+83.3%) | -$46.83 M(+22.2%) |
| Sep 2018 | - | -$38.34 M(+11.5%) |
| Jun 2018 | - | -$34.37 M(+16.4%) |
| Mar 2018 | - | -$29.54 M(+15.6%) |
| Dec 2017 | -$25.55 M(-84.2%) | -$25.55 M(+19.7%) |
| Sep 2017 | - | -$21.34 M(-86.9%) |
| Jun 2017 | - | -$162.92 M(+0.4%) |
| Mar 2017 | - | -$162.25 M(+0.6%) |
| Dec 2016 | -$161.32 M(+5.2%) | -$161.32 M(+1.1%) |
| Sep 2016 | - | -$159.61 M(+1.3%) |
| Jun 2016 | - | -$157.60 M(+1.4%) |
| Mar 2016 | - | -$155.50 M(+1.4%) |
| Dec 2015 | -$153.34 M(+8.5%) | -$153.34 M(+1.6%) |
| Sep 2015 | - | -$150.96 M(+1.9%) |
| Jun 2015 | - | -$148.17 M(+2.4%) |
| Mar 2015 | - | -$144.67 M(+2.4%) |
| Dec 2014 | -$141.32 M(+11.9%) | -$141.32 M(+2.4%) |
| Sep 2014 | - | -$137.96 M(+2.9%) |
| Jun 2014 | - | -$134.09 M(+3.2%) |
| Mar 2014 | - | -$129.92 M(+2.9%) |
| Dec 2013 | -$126.27 M(+15.2%) | -$126.27 M(+3.1%) |
| Sep 2013 | - | -$122.51 M(+4.9%) |
| Jun 2013 | - | -$116.79 M(+2.6%) |
| Mar 2013 | - | -$113.79 M(+3.8%) |
| Dec 2012 | -$109.61 M(+8.9%) | -$109.61 M(+1.9%) |
| Sep 2012 | - | -$107.58 M(+2.2%) |
| Jun 2012 | - | -$105.22 M(+2.1%) |
| Mar 2012 | - | -$103.05 M(+2.4%) |
| Dec 2011 | -$100.68 M | -$100.68 M(+1.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2011 | - | -$98.80 M(+1.3%) |
| Jun 2011 | - | -$97.51 M(+1.5%) |
| Mar 2011 | - | -$96.02 M(+1.4%) |
| Dec 2010 | -$94.71 M(+6.1%) | -$94.71 M(+1.0%) |
| Sep 2010 | - | -$93.78 M(+1.4%) |
| Jun 2010 | - | -$92.49 M(+2.0%) |
| Mar 2010 | - | -$90.67 M(+1.6%) |
| Dec 2009 | -$89.24 M(-0.4%) | -$89.24 M(+1.3%) |
| Sep 2009 | - | -$88.09 M(-2.5%) |
| Jun 2009 | - | -$90.31 M(+1.0%) |
| Mar 2009 | - | -$89.45 M(-0.1%) |
| Dec 2008 | -$89.56 M(+15.3%) | -$89.56 M(+2.3%) |
| Sep 2008 | - | -$87.58 M(+3.7%) |
| Jun 2008 | - | -$84.45 M(+4.5%) |
| Mar 2008 | - | -$80.81 M(+4.0%) |
| Dec 2007 | -$77.71 M(+31.6%) | -$77.71 M(+50.8%) |
| Sep 2007 | - | -$51.53 M(+8.2%) |
| Jun 2007 | - | -$47.61 M(+11.5%) |
| Mar 2007 | - | -$42.70 M(-27.7%) |
| Dec 2006 | -$59.04 M(+191.4%) | -$59.04 M(+84.3%) |
| Sep 2006 | - | -$32.04 M(+4.3%) |
| Jun 2006 | - | -$30.71 M(+16.4%) |
| Mar 2006 | - | -$26.39 M(+30.2%) |
| Dec 2005 | -$20.26 M(+326.9%) | -$20.26 M(-3.4%) |
| Sep 2005 | - | -$20.97 M(+29.1%) |
| Jun 2005 | - | -$16.24 M(+91.2%) |
| Mar 2005 | - | -$8.49 M(+78.9%) |
| Dec 2004 | -$4.75 M(+142.7%) | -$4.75 M(+140.1%) |
| Sep 2004 | - | -$1.98 M(+46.6%) |
| Jun 2004 | - | -$1.35 M(-29.9%) |
| Mar 2004 | - | -$1.92 M(+1.3%) |
| Dec 2003 | - | -$1.90 M(-2.9%) |
| Sep 2003 | -$1.96 M(+4.7%) | -$1.96 M(-2.3%) |
| Jun 2003 | - | -$2.00 M(+2.1%) |
| Mar 2003 | - | -$1.96 M(+2.4%) |
| Dec 2002 | - | -$1.92 M(+2.6%) |
| Sep 2002 | -$1.87 M(+11.9%) | -$1.87 M(+2.0%) |
| Jun 2002 | - | -$1.83 M(+2.8%) |
| Mar 2002 | - | -$1.78 M(+6.8%) |
| Sep 2001 | -$1.67 M(+52.6%) | -$1.67 M(+6.9%) |
| Jun 2001 | - | -$1.56 M(+9.1%) |
| Mar 2001 | - | -$1.43 M(+12.3%) |
| Dec 2000 | - | -$1.28 M(+16.6%) |
| Sep 2000 | -$1.09 M(+473.1%) | -$1.09 M(+58.8%) |
| Jun 2000 | - | -$689.00 K(+46.7%) |
| Mar 2000 | - | -$469.60 K(+63.8%) |
| Dec 1999 | - | -$286.70 K(+50.2%) |
| Sep 1999 | -$190.90 K | -$190.90 K |
FAQ
- What is Acer Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Acer Therapeutics?
- What is Acer Therapeutics annual retained earnings year-on-year change?
- What is Acer Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Acer Therapeutics?
- What is Acer Therapeutics quarterly retained earnings year-on-year change?
What is Acer Therapeutics annual retained earnings?
The current annual retained earnings of ACER is -$140.75 M
What is the all time high annual retained earnings for Acer Therapeutics?
Acer Therapeutics all-time high annual retained earnings is -$190.90 K
What is Acer Therapeutics annual retained earnings year-on-year change?
Over the past year, ACER annual retained earnings has changed by -$26.24 M (-22.91%)
What is Acer Therapeutics quarterly retained earnings?
The current quarterly retained earnings of ACER is -$165.12 M
What is the all time high quarterly retained earnings for Acer Therapeutics?
Acer Therapeutics all-time high quarterly retained earnings is -$190.90 K
What is Acer Therapeutics quarterly retained earnings year-on-year change?
Over the past year, ACER quarterly retained earnings has changed by -$38.76 M (-30.68%)